Stock evidence summary

NTLA — Intellia Therapeutics, Inc. - Common Stock

Indicator close (not current quote)
$15.67
Evidence score
44
Price/source label
indicator close — not current quote
Confidence
limited

Educational research only. ANNbroker is not a broker, dealer, investment adviser, or trading platform. Evidence summaries are not trade recommendations. Market data may be delayed, cached, incomplete, or inaccurate; use brokerage/exchange quotes for order entry. Options involve risk.

What could happen next

scenario, not forecast

NTLA currently appears positive evidence with pullback risk based on available indicator evidence. This is a scenario summary, not a forecast; confidence is partial, limited.

Could happen

  • Price could continue showing positive pressure if trend, momentum, and volume evidence remain aligned.
  • A pullback could still happen if the move is extended, volume weakens, or price/source confidence changes.
  • ATR context suggests recent one-day movement has been around 8.28% ($1.30). That describes recent movement range, not future direction.

Supports

  • Price is above the 20-day moving average (13.52).
  • Price is above the 50-day moving average (13.76).
  • Price is above the 200-day moving average (13.47).
  • Supertrend state is bullish.

Argues against

  • ATR risk is elevated at 8.28% of price; position sizing and options premium risk may matter more.
  • Price is above the upper Bollinger Band, which can indicate extension risk.
  • Price is 44.53% below its 52-week high.

Risks / confidence

  • Data trust note: only one OHLCV source verified for this cycle.
  • Options activity is not confirmed in the starter universe; OptionsTransparencyAgent will mark contract-liquidity context as not confirmed unless an options-chain source is available.
  • Options context: elevated ATR can mean expensive premium, wider spreads, or a faster move required to overcome cost.
  • Price/source confidence: indicator close — not current quote.
  • Indicator close is a research input for RSI/MACD/ATR/backtesting. It is not a live quote.
  • Current quote display is locked until fresh multi-source price checks pass. Use a brokerage/exchange quote for current price and order entry.
  • Confidence: partial, limited
  • Uses could/may/possible language. This is not a recommendation, prediction, or order-entry quote.

Indicator evidence

Positive / supportive evidence

  • Price is above the 20-day moving average (13.52).
  • Price is above the 50-day moving average (13.76).
  • Price is above the 200-day moving average (13.47).
  • Supertrend state is bullish.
  • Parabolic SAR is below price, supporting the current upward structure.
  • MACD histogram is positive (0.2817), showing upward momentum pressure.
  • RSI is constructive without being extreme (61.82).
  • 20-day rate of change is positive (27.81%).

Negative / opposing evidence

  • ATR risk is elevated at 8.28% of price; position sizing and options premium risk may matter more.
  • Price is above the upper Bollinger Band, which can indicate extension risk.
  • Price is 44.53% below its 52-week high.

Watchouts

Price/source confidence

Quote state
quote_locked
Label
indicator close — not current quote
ATR %
8.28%
1-day ATR context
$1.2972

Numbers table

Close15.67
Score44
Trend score23
Momentum score17
Volume/flow score20
Volatility/risk score-9
RSI 1461.8227
MACD histogram0.2817
ADX 1419.0729
ATR $1.2972
ATR %8.278
1-day ATR low14.3728
1-day ATR high16.9672
Relative volume 201.33
CMF 200.1437
Donchian position0.7846
Bollinger %B1.0091
Above VWAP 201

Weekly movement / options context

These are probability-readiness notes, not trade suggestions. Direction odds stay locked until Backtesting Agents validate a model for this symbol/timeframe.

1-week ATR range context
18.51%
Rise % over 1 week
pending validated direction model
Fall % over 1 week
pending validated direction model
Put/call odds
input-required

Open options probability sandbox Open backtesting notes

Backtesting status

Backtesting
background validation in progress
Public win-rate claims
locked until validated

Backtesting agents must validate indicator/timeframe win rates against historical data before the site displays them as measured results.

News/context

No stock-specific news context listed in the current public data.